换一批Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511].
第一作者：
Xinxue,Liu
第一单位：
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
作者：
Xinxue,Liu [1]
;
Alasdair Ps,Munro [2]
;
Shuo,Feng [1]
;
Leila,Janani [3]
;
Parvinder K,Aley [4]
;
Gavin,Babbage [5]
;
David,Baxter [6]
;
Marcin,Bula [7]
;
Katrina,Cathie [2]
;
Krishna,Chatterjee [8]
;
Wanwisa,Dejnirattisai [9]
;
Kate,Dodd [7]
;
Yvanne,Enever [10]
;
Ehsaan,Qureshi [11]
;
Anna L,Goodman [12]
;
Christopher A,Green [11]
;
Linda,Harndahl [13]
;
John,Haughney [14]
;
Alexander,Hicks [13]
;
Agatha A,van der Klaauw [15]
;
Jonathan,Kwok [16]
;
Vincenzo,Libri [17]
;
Martin J,Llewelyn [18]
;
Alastair C,McGregor [19]
;
Angela M,Minassian [20]
;
Patrick,Moore [21]
;
Mehmood,Mughal [6]
;
Yama F,Mujadidi [22]
;
Kyra,Holliday [23]
;
Orod,Osanlou [24]
;
Rostam,Osanlou [25]
;
Daniel R,Owens [2]
;
Mihaela,Pacurar [2]
;
Adrian,Palfreeman [26]
;
Daniel,Pan [26]
;
Tommy,Rampling [17]
;
Karen,Regan [27]
;
Stephen,Saich [5]
;
Teona,Serafimova [28]
;
Dinesh,Saralaya [27]
;
Gavin R,Screaton [9]
;
Sunil,Sharma [18]
;
Ray,Sheridan [29]
;
Ann,Sturdy [19]
;
Piyada,Supasa [9]
;
Emma C,Thomson [30]
;
Shirley,Todd [29]
;
Chris,Twelves [23]
;
Robert C,Read [2]
;
Sue,Charlton [31]
;
Bassam,Hallis [31]
;
Mary,Ramsay [32]
;
Nick,Andrews [32]
;
Teresa,Lambe [1]
;
Jonathan S,Nguyen-Van-Tam [33]
;
Victoria,Cornelius [3]
;
Matthew D,Snape [4]
;
Saul N,Faust [34]
;
COV-BOOST study group
作者单位：
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
[1]
NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
[2]
Imperial Clinical Trials Unit, Imperial College London, London, UK.
[3]
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
[4]
NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
[5]
Stockport NHS Foundation Trust, Stockport, UK.
[6]
NIHR Liverpool and Broadgreen Clinical Research Facility, Liverpool, UK.
[7]
NIHR Cambridge Clinical Research Facility, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
[8]
Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
[9]
PHARMExcel, Welwyn Garden City, Hertfordshire, UK.
[10]
NIHR/Wellcome Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
[11]
Department of Infection, Guy's and St Thomas' NHS Foundation Trust, London, UK; MRC Clinical Trials Unit, University College London, London, UK.
[12]
Portsmouth Hospitals University NHS Trust, Portsmouth, UK.
[13]
Queen Elizabeth University Hospital, NHS Greater Glasgow & Clyde, Glasgow, UK.
[14]
Wellcome-MRC Institute of Metabolic Science, Department of Clinical Biochemistry, University of Cambridge, Cambridge, UK.
[15]
Cancer Research UK Oxford Centre, University of Oxford, Oxford, UK.
[16]
NIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.
[17]
University Hospitals Sussex NHS Foundation Trust, Brighton, UK.
[18]
Department of Infectious Diseases and Tropical Medicine, London Northwest University Healthcare, London, UK.
[19]
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
[20]
The Adam Practice, Poole, UK.
[21]
NIHR Oxford Biomedical Research Centre, Oxford, UK.
[22]
NIHR Leeds Clinical Research Facility, Leeds Teaching Hospitals Trust and University of Leeds, Leeds, UK.
[23]
Public Health Wales, Betsi Cadwaladr University Health Board, Bangor University, Bangor, UK.
[24]
University of Liverpool, Liverpool, UK.
[25]
University Hospitals of Leicester NHS Trust, University of Leicester, Leicester, UK.
[26]
Bradford Institute for Health Research and Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.
[27]
Department of Infection, Guy's and St Thomas' NHS Foundation Trust, London, UK.
[28]
Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter, UK.
[29]
Queen Elizabeth University Hospital, NHS Greater Glasgow & Clyde, Glasgow, UK; MRC University of Glasgow Centre for Virus Research, Glasgow, UK.
[30]
UK Health Security Agency, Porton Down, UK.
[31]
UK Health Security Agency, Colindale, London, UK.
[32]
Division of Epidemiology and Public Health, University of Nottingham School of Medicine, UK.
[33]
NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK. Electronic address: s.faust@soton.ac.uk.
[34]
DOI
10.1016/j.jinf.2023.03.025
PMID
37055303
发布时间
2025-05-30
- 浏览4
The Journal of infection
The Journal of infection
540-541页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
